"The FAST Generics Act represents market-based reforms that will increase competition and ensure that lifesaving medications can safely reach patients at an affordable price." Read More
American Academy of Family Physicians Joins CSRxP The Campaign for Sustainable… Read More
"We must ‘bring down the artificially high price of drugs and bring them down immediately.’ That’s what the President said in his address to Congress – and the American people agree. Read More
We applaud President Trump for making the out-of-control prices of prescription drugs a priority in his Administration. Read More
"No amount of advertising will make hardworking families forget the consequences of their out-of-control drug costs." Read More
A new HHS Office of the Inspector General report finds that high-priced prescription drugs are threatening the sustainability of the taxpayer-funded Medicare Part D program. Read More
"We are encouraged to see the president-elect is ready to take action. We look forward to working with the new Administration and the new Congress to find solutions to fix the broken prescription drug market, and to help make life-saving medications more affordable for the patients who need them.” Read More
The drug industry is front and center in a national dialogue. How do we make sure patients around the world can get the medicines they need? Can we balance costs and the need for innovation? Pharma leaders answer Forbes’ questions – and yours. Read More
Based on Novo Nordisk’s announcement, it is clear that the company will continue to hike insulin prices, despite the financial burdens already facing patients. “The prescription drug market is clearly broken when limiting yearly price increases to ten percent is considered bighearted,” said John Rother. Read More
“Millions of Americans rely on prescription drugs to get and stay healthy. The challenges of dealing with a health condition are only made worse when pharmaceutical companies take advantage of patients and raising prices where they see an increased market opportunity,” said CSRxP Executive Director John Rother. Read More
The American Diabetes Association's board of directors is calling on Congress to hold hearings to investigate dramatic increases in insulin prices and to take action to ensure that people have affordable access to the essential drug. Read More
“The newly-elected Congress has a mandate to pass market-based solutions, such as legislation that would give patients more choices in their medications. Lowering drug prices is the number one healthcare issue for voters — and elected officials are going to continue to hear from their constituents until drug prices are more affordable.” Read More